Research & Development

色大姐综合网 色天使在线色天使最新电影色天使在线影院超碰IDC:二季全球智能手机出货量下降2.3% 华为增长8.3%

發布時間︰

一四 色大姐综合网 色天使在线 色天使最新电影   急於路的汪大有注意「雷克斯」的作,「雷克斯,上就到院了,你一定持住!到有!」 受訪用戶︰不通知漲價算不算違約色天使在线影院超碰   Roy心里莫名地閃過一絲緊張,厲聲道,「你睜開眼楮看著我,奈特!」

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.


Connect? Registries


The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo